regenerative medicine · clinical context

Alzheimer's Memory Preservation
& Cognitive Support

Umbilical cord mesenchymal stem cells as core regenerative therapy

Integrated protocol with physical therapy, nutritional medicine, and minimally invasive techniques. Objective: preserve cognitive function and improve quality of life through neuroprotection and immunomodulation.

UC-MSC core Physical therapy Nutritional medicine Minimally invasive
Regenerative Neurology
umbilical cord derived

Alzheimer's Disease
Memory Preservation

Umbilical cord mesenchymal stem cells exert neuroprotective effects through secretion of brain-derived neurotrophic factor and modulation of microglial activation. This regenerative approach targets synaptic integrity and neuronal survival to preserve cognitive function.

Core therapy: UC-MSC intravenous & intrathecal administration. Supportive: physical therapy for functional maintenance; nutritional medicine to reduce oxidative burden.

Cognitive Support
& Neuroprotection

Beyond memory preservation, umbilical cord mesenchymal stem cells provide comprehensive cognitive support through reduction of amyloid burden, promotion of neurogenesis, and resolution of chronic neuroinflammation via paracrine signaling mechanisms.

Regenerative framework: mesenchymal stem cell infusion combined with targeted physical therapy and nutritional support. Minimally invasive techniques optimize delivery for maximum cognitive benefit.

Considerations for the Integral Approach

This integral framework combines UC-MSC, physical therapy, and nutritional medicine.

Meet Our Doctors →

🧠 Alzheimer's Guide

Download our scientific summary: "UC-MSC in Neurodegeneration – 2025 Update"

Get your free guide

No spam. Science-based information only.

Deep Dive: The Science Behind the Protocol

The rationale for using umbilical cord MSCs in Alzheimer's is grounded in their biological properties. MSCs target neuroinflammation by suppressing microglial activation, provide neurotrophic support (BDNF) that acts as "fertilizer" for brain cells, and clinical reviews (up to June 2025) confirm feasibility and general safety. While therapeutic efficacy is still investigational, the integrated protocol aligns with preclinical evidence for synaptic integrity and cognitive support.

UC-MSC · amyloid modulation · paracrine signaling

UC-MSC · regenerative neurology
Review Clinical Protocol
Live Chat Free Consultation